Elhízás: nyitott vizsgálatok itt: Kanada
99 trials · From ClinicalTrials.gov, checked 2026. nov. 10.. Ask the study team whether a trial fits you.
3. fázisToborozTrial-stage medicine
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Brampton, Calgary, Hamilton, Québec, Sarnia, Surrey, Trois-Rivières
- Age
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045EU 2025-523104-71-00Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Brampton, Calgary, Greater Sudbury, Montreal, Québec, Sherbrooke, Toronto, Vancouver
- Age
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058EU 2025-523106-32-00Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Calgary, Guelph, Hamilton, Joliette, Montreal, Stouffville, Surrey, Toronto, Vancouver
- Age
- 18 év and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509EU 2025-523295-23-00Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Where
- Hamilton, Moncton, Surrey, Toronto
- Age
- 18 év and over
- People
- 954 worldwide
- Run by
- Pfizer
See details and how to joinNCT07595549EU 2026-525318-75-00Regiszter frissítve: 2026-11-05
3. fázisToborozTrial-stage medicine
Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
- Where
- Vancouver
- Age
- 18 év and over
- People
- 1300 worldwide
- Run by
- Amgen
See details and how to joinNCT07866066EU 2025-523772-22-00Regiszter frissítve: 2026-11-05
3. fázisToborzás még nem indultTrial-stage medicine
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
- Where
- Halifax, Hamilton, London, Moncton, Québec, Trois-Rivières, Vancouver, Victoria
- Age
- 18 év and over
- People
- 1408 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07919405Regiszter frissítve: 2026-11-05
3. fázisToborozTrial-stage medicine
A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
- Where
- Sarnia
- Age
- 18 év and over
- People
- 656 worldwide
- Run by
- Pfizer
See details and how to joinNCT07919678EU 2026-526328-34-00Regiszter frissítve: 2026-11-05
2. fázisToborozTrial-stage medicine
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Where
- Brampton, Chicoutimi, Hamilton, Longueuil, Moncton, Sarnia, Toronto, Waterloo
- Age
- 18 év to 75 év
- People
- 200 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06897475EU 2024-520328-27-00Regiszter frissítve: 2026-11-04
3. fázisToborozTrial-stage medicine
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- London, Montreal, Ottawa, Vancouver
- Age
- 18 év to 70 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086EU 2024-520209-38-00Regiszter frissítve: 2026-11-04
3. fázisToborozTrial-stage medicine
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Edmonton, London, Montreal, Ottawa, Vancouver
- Age
- 18 év to 70 év
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099EU 2024-520210-21-00Regiszter frissítve: 2026-11-04
3. fázisToborozTrial-stage medicine
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
- Where
- Kelowna, Lévis, Oakville, Québec, Red Deer, Toronto
- Age
- 18 év and over
- People
- 1000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07202884EU 2025-522514-23-00Regiszter frissítve: 2026-11-04
3. fázisToborozTrial-stage medicine
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Where
- Guelph, Québec, Stouffville, Toronto, Victoriaville
- Age
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07353931EU 2025-523768-19-00Regiszter frissítve: 2026-11-04
3. fázisToborozTrial-stage medicine
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Where
- Calgary, Lévis, Québec, Saint-Laurent, Toronto, Trois-Rivières
- Age
- 18 év and over
- People
- 800 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07369011EU 2025-523769-11-00Regiszter frissítve: 2026-11-04
No phaseToborozResearch participation
OBEDIAM: Therapeutic Patient Education in Adults Living With Obesity, Diabetes, and Metabolic Disorders
- Where
- Québec
- Age
- 18 év to 80 év
- People
- 42
- Run by
- CHU de Quebec-Universite Laval
See details and how to joinNCT07668661Regiszter frissítve: 2026-11-03
3. fázisToborzás még nem indultTrial-stage medicine
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Brampton, Calgary, Halifax, Kelowna, Montreal, Pointe-Claire, Québec, St. John's, Terrebonne, Waterloo
- Age
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633EU 2026-525919-14-00Regiszter frissítve: 2026-11-03
3. fázisToborozTrial-stage medicine
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Brampton, Calgary, Guelph, Hamilton, Mississauga, Moncton, Montreal, New Westminster, North York, Québec, Saint-Charles-Borromée, Scarborough Village, Sherbrooke, Stoney Creek, Stouffville, Surrey, Toronto, Truro, Victoria
- Age
- 18 év and over
- People
- 2500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725EU 2025-523379-41-00Regiszter frissítve: 2026-10-30
3. fázisToborozTrial-stage medicine
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Brampton, Cambridge, Chicoutimi, Edmonton, Montreal, Newmarket, North York, Peterborough, Sarnia, Scarborough Village, Sherbrooke, Stoney Creek, Thunder Bay, Toronto, Trois-Rivières, Waterloo, Winchester, Winnipeg
- Age
- 18 év to 99 év
- People
- 5056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459Regiszter frissítve: 2026-10-29
3. fázisToborozTrial-stage medicine
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Calgary, Hamilton, Joliette, Markham, Moncton, Montreal, North York, Québec, Sarnia, Scarborough Village, Stoney Creek, Stouffville, Toronto, Trois-Rivières, Truro, Vancouver
- Age
- 18 év and over
- People
- 1500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270Regiszter frissítve: 2026-10-28
4. fázisToborozTrial-stage medicine
Mechanisms of Weight Loss: Tirzepatide vs Semaglutide
- Where
- Hamilton
- Age
- 18 év to 60 év
- People
- 80
- Run by
- McMaster University
See details and how to joinNCT07900074Regiszter frissítve: 2026-10-28
4. fázisToborozTrial-stage medicine
Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss
- Where
- Montreal
- Age
- 35 év to 55 év
- People
- 240
- Run by
- Alain Dagher
See details and how to joinNCT07592546Regiszter frissítve: 2026-10-26
3. fázisToborozTrial-stage medicine
Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance
- Where
- Edmonton
- Age
- 12 év to 18 év
- People
- 90
- Run by
- University of Alberta
See details and how to joinNCT04578652Regiszter frissítve: 2026-10-23
2/3. fázisToborozTrial-stage medicine
Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.
- Where
- Montreal
- Age
- 18 év to 65 év
- People
- 40
- Run by
- McGill University Health Centre/Research Institute of the McGill University Health Centre
See details and how to joinNCT07891156Regiszter frissítve: 2026-10-23
1. fázisToborozTrial-stage medicine
A Study to Evaluate ALN-6222 in Participants With Obesity
- Where
- Mount Royal
- Age
- 18 év to 65 év
- People
- 88
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07624071Regiszter frissítve: 2026-10-21
No phaseToborzás még nem indultResearch participation
EAT SMART Teen Study
- Where
- Ottawa
- Age
- 12 év to 17 év
- People
- 170
- Run by
- Gary Goldfield
See details and how to joinNCT07130838Regiszter frissítve: 2026-10-20
1/2. fázisToborozTrial-stage medicine
A Study to Evaluate ALN-2232 in Participants With Obesity
- Where
- Mount Royal
- Age
- 18 év to 65 év
- People
- 156
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07463846Regiszter frissítve: 2026-10-13
Minden vizsgálat (Elhízás) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.